ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ACHV Achieve Life Sciences Inc

4.70
0.125 (2.73%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Achieve Life Sciences Inc ACHV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.125 2.73% 4.70 23:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.57 4.48 4.64 4.61 4.575
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202407:00GLOBEAchieve Life Sciences to Announce First Quarter Financial..
11/4/202407:00GLOBEAchieve Life Sciences to Present at Life Science Innovation..
28/3/202415:01GLOBEAchieve Life Sciences Reports Financial Results for Fourth..
20/3/202407:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline ORCA..
14/3/202407:00GLOBEAchieve Life Sciences to Announce Fourth Quarter and..
06/3/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:41EDGAR2Form 8-K - Current report
29/2/202415:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202407:01GLOBEAchieve Life Sciences Reaches Agreement with the FDA on..
29/2/202407:00GLOBEAchieve Life Sciences Announces Pricing of up to $124.2..
27/2/202414:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202413:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202418:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202418:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:04EDGAR2Form 8-K - Current report
09/11/202315:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:00GLOBEAchieve Life Sciences Reports Financial Results for Third..
26/10/202307:00GLOBEAchieve Life Sciences to Announce Third Quarter 2023..
03/10/202307:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
11/9/202307:00GLOBEAchieve Life Sciences Announces Presentation of..
07/9/202307:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
14/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:06EDGAR2Form 8-K - Current report
14/8/202315:00GLOBEAchieve Life Sciences Reports Financial Results for Second..
01/8/202307:00GLOBEAchieve Life Sciences to Announce Second Quarter 2023..
18/7/202307:00GLOBEAchieve Life Sciences Announces Presentation at 2023..
11/7/202310:23GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..
06/6/202307:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
25/5/202308:00GLOBEAchieve Life Sciences Announces Pricing of $16.5 Million..
23/5/202305:00GLOBEAchieve Life Sciences Reports Statistically Significant..
17/5/202307:00GLOBEAchieve Life Sciences Announces Refinancing of Outstanding..
09/5/202315:05GLOBEAchieve Life Sciences Reports Financial Results for First..

Su Consulta Reciente

Delayed Upgrade Clock